Onderneming Discovery Laboratories, Inc. Nasdaq
Aandelen
US2546684034
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
16/04 | Windtree Therapeutics, Inc. rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
10/04 | Transcript : Windtree Therapeutics, Inc. - Shareholder/Analyst Call |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 01-02-16 |
Eric Curtis
COO | Chief Operating Officer | 56 | 09-03-20 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Steven Simonson
CTO | Chief Tech/Sci/R&D Officer | 65 | 20-05-14 |
Jamie McAndrew
AUD | Comptroller/Controller/Auditor | 44 | 01-11-13 |
Diane Carman
LAW | General Counsel | 55 | 01-07-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 03-02-21 |
Mark Strobeck
BRD | Director/Board Member | 53 | 22-06-23 |
Leslie Williams
BRD | Director/Board Member | 64 | 03-02-21 |
Craig Fraser
CEO | Chief Executive Officer | 59 | 01-02-16 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 510 178 | 486 423 ( 95,34 %) | 0 ( 0,000011 %) | 95,34 % |
Bedrijfsgegevens
Windtree Therapeutics, Inc.
2600 Kelly Road Suite 100
18976-3622, Warrington
+
http://www.windtreetx.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,77% | 49,18 mld. | |
+1,00% | 42,11 mld. | |
+50,47% | 40,37 mld. | |
-5,26% | 28,85 mld. | |
+13,68% | 26,09 mld. | |
-22,99% | 18,71 mld. | |
+8,22% | 13,26 mld. | |
+32,41% | 12,32 mld. | |
-1,62% | 11,99 mld. |
- Beurs
- Aandelen
- Koers WINT
- Koers
- Onderneming Discovery Laboratories, Inc.